 |
||||
|
||||
|
||||
|
||||
The Journal of Neuroscience, October 5, 2005, 25(40):9152-9161; doi:10.1523/JNEUROSCI.3001-05.2005
Previous Article | Next Article
Neurobiology of Disease
CHIP Suppresses Polyglutamine Aggregation and Toxicity In Vitro and In Vivo
Victor M. Miller,1,2 Rick F. Nelson,1,3,4 Cynthia M. Gouvion,1 Aislinn Williams,1,3,4 Edgardo Rodriguez-Lebron,1 Scott Q. Harper,5 Beverly L. Davidson,1,2,3,5 Michael R. Rebagliati,2,6 andHenry L. Paulson1,2,3,4 1Department of Neurology, 2Graduate Program in Genetics, 3Graduate Program in Neuroscience, 4Medical Scientist Training Program, 5Department of Internal Medicine and Department of Physiology and Biophysics, and 6Department of Anatomy and Cell Biology, University of Iowa Roy J. and Lucille A. Carver College of Medicine, Iowa City, Iowa 52242
Huntington's disease (HD) and other polyglutamine (polyQ) neurodegenerative diseases are characterized by neuronal accumulation of the disease protein, suggesting that the cellular ability to handle abnormal proteins is compromised. As both a cochaperone and ubiquitin ligase, the C-terminal Hsp70 (heat shock protein 70)-interacting protein (CHIP) links the two major arms of protein quality control, molecular chaperones, and the ubiquitin-proteasome system. Here, we demonstrate that CHIP suppresses polyQ aggregation and toxicity in transfected cell lines, primary neurons, and a novel zebrafish model of disease. Suppression by CHIP requires its cochaperone function, suggesting that CHIP acts to facilitate the solubility of mutant polyQ proteins through its interactions with chaperones. Conversely, HD transgenic mice that are haploinsufficient for CHIP display a markedly accelerated disease phenotype. We conclude that CHIP is a critical mediator of the neuronal response to misfolded polyQ protein and represents a potential therapeutic target in this important class of neurodegenerative diseases.
Key words: polyQ; CHIP; zebrafish; neurodegeneration; proteasome; molecular chaperones
Received July 8, 2004; revised August 16, 2005; accepted August 17, 2005.
This article has been cited by other articles:
L.-R. Zeng, C. H. Park, R.C. Venu, J. Gough, and G.-L. Wang
Classification, Expression Pattern, and E3 Ligase Activity Assay of Rice U-Box-Containing Proteins
Mol Plant, September 1, 2008; 1(5): 800 - 815.
[Abstract] [Full Text] [PDF]
T. C. Tuoc and A. Stoykova
Trim11 modulates the function of neurogenic transcription factor Pax6 through ubiquitin-proteosome system
Genes & Dev., July 15, 2008; 22(14): 1972 - 1986.
[Abstract] [Full Text] [PDF]
J. E. Tetzlaff, P. Putcha, T. F. Outeiro, A. Ivanov, O. Berezovska, B. T. Hyman, and P. J. McLean
CHIP Targets Toxic {alpha}-Synuclein Oligomers for Degradation
J. Biol. Chem., June 27, 2008; 283(26): 17962 - 17968.
[Abstract] [Full Text] [PDF]
J.-N. Min, R. A. Whaley, N. E. Sharpless, P. Lockyer, A. L. Portbury, and C. Patterson
CHIP Deficiency Decreases Longevity, with Accelerated Aging Phenotypes Accompanied by Altered Protein Quality Control
Mol. Cell. Biol., June 15, 2008; 28(12): 4018 - 4025.
[Abstract] [Full Text] [PDF]
A. L. Orr, S. Huang, M. A. Roberts, J. C. Reed, S. Li, and X.-J. Li
Sex-dependent Effect of BAG1 in Ameliorating Motor Deficits of Huntington Disease Transgenic Mice
J. Biol. Chem., June 6, 2008; 283(23): 16027 - 16036.
[Abstract] [Full Text] [PDF]
A. Mishra, P. Dikshit, S. Purkayastha, J. Sharma, N. Nukina, and N. R. Jana
E6-AP Promotes Misfolded Polyglutamine Proteins for Proteasomal Degradation and Suppresses Polyglutamine Protein Aggregation and Toxicity
J. Biol. Chem., March 21, 2008; 283(12): 7648 - 7656.
[Abstract] [Full Text] [PDF]
R. Lemmens, A. Van Hoecke, N. Hersmus, V. Geelen, I. D'Hollander, V. Thijs, L. Van Den Bosch, P. Carmeliet, and W. Robberecht
Overexpression of mutant superoxide dismutase 1 causes a motor axonopathy in the zebrafish
Hum. Mol. Genet., October 1, 2007; 16(19): 2359 - 2365.
[Abstract] [Full Text] [PDF]
V. Tripathi, A. Ali, R. Bhat, and U. Pati
CHIP Chaperones Wild Type p53 Tumor Suppressor Protein
J. Biol. Chem., September 28, 2007; 282(39): 28441 - 28454.
[Abstract] [Full Text] [PDF]
A. L. Lumsden, T. L. Henshall, S. Dayan, M. T. Lardelli, and R. I. Richards
Huntingtin-deficient zebrafish exhibit defects in iron utilization and development
Hum. Mol. Genet., August 15, 2007; 16(16): 1905 - 1920.
[Abstract] [Full Text] [PDF]
M. F. N. Rosser, E. Washburn, P. J. Muchowski, C. Patterson, and D. M. Cyr
Chaperone Functions of the E3 Ubiquitin Ligase CHIP
J. Biol. Chem., August 3, 2007; 282(31): 22267 - 22277.
[Abstract] [Full Text] [PDF]
H. Adachi, M. Waza, K. Tokui, M. Katsuno, M. Minamiyama, F. Tanaka, M. Doyu, and G. Sobue
CHIP Overexpression Reduces Mutant Androgen Receptor Protein and Ameliorates Phenotypes of the Spinal and Bulbar Muscular Atrophy Transgenic Mouse Model
J. Neurosci., May 9, 2007; 27(19): 5115 - 5126.
[Abstract] [Full Text] [PDF]
P. Kumar, R. K. Ambasta, V. Veereshwarayya, K. M. Rosen, K. S. Kosik, H. Band, R. Mestril, C. Patterson, and H. W. Querfurth
CHIP and HSPs interact with {beta}-APP in a proteasome-dependent manner and influence A{beta} metabolism
Hum. Mol. Genet., April 1, 2007; 16(7): 848 - 864.
[Abstract] [Full Text] [PDF]
I. Al-Ramahi, Y. C. Lam, H.-K. Chen, B. de Gouyon, M. Zhang, A. M. Perez, J. Branco, M. de Haro, C. Patterson, H. Y. Zoghbi, et al.
CHIP Protects from the Neurotoxicity of Expanded and Wild-type Ataxin-1 and Promotes Their Ubiquitination and Degradation
J. Biol. Chem., September 8, 2006; 281(36): 26714 - 26724.
[Abstract] [Full Text] [PDF]
C. A. Dickey, M. Yue, W.-L. Lin, D. W. Dickson, J. H. Dunmore, W. C. Lee, C. Zehr, G. West, S. Cao, A. M. K. Clark, et al.
Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species.
J. Neurosci., June 28, 2006; 26(26): 6985 - 6996.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|